Corient Private Wealth’s UBS Group UBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.48M Sell
110,065
-122,832
-53% -$5.26M 0.01% 987
2025
Q4
$10.8M Buy
232,897
+108,086
+87% +$4.37M 0.01% 754
2025
Q3
$5.12M Buy
124,811
+29,130
+30% +$1.13M 0.01% 705
2025
Q2
$3.24M Buy
95,681
+21,829
+30% +$675K ﹤0.01% 846
2025
Q1
$2.26M Buy
73,852
+562
+0.8% +$18.7K ﹤0.01% 931
2024
Q4
$2.22M Buy
73,290
+797
+1% +$25.3K ﹤0.01% 957
2024
Q3
$2.24M Buy
72,493
+8,395
+13% +$252K ﹤0.01% 1045
2024
Q2
$1.89M Buy
64,098
+12,762
+25% +$379K ﹤0.01% 1043
2024
Q1
$1.58M Buy
51,336
+8,836
+21% +$261K ﹤0.01% 1139
2023
Q4
$1.31M Sell
42,500
-2,815
-6% -$74K ﹤0.01% 1179
2023
Q3
$1.11M Sell
45,315
-123
-0.3% -$2.87K ﹤0.01% 1154
2023
Q2
$919K Buy
45,438
+332
+0.7% +$6.67K ﹤0.01% 1190
2023
Q1
$963K Buy
45,106
+27,415
+155% +$572K ﹤0.01% 1104
2022
Q4
$329K Buy
+17,691
New +$301K ﹤0.01% 1302

Other funds holding UBS

Corient Private Wealth's UBS Position: Q1 2026 in Review

Corient Private Wealth reduced its UBS Group (UBS) stake by 53% in Q1 2026, selling an estimated $5.26M and leaving 110,065 shares worth $3.48M. The position accounts for 0.01% of the portfolio, ranked #987.

Corient Private Wealth first reported a position in UBS in Q4 2022 and has held it in 14 quarters since. The position peaked at $10.8M in Q4 2025. 679 funds tracked by Wall St. Rank hold UBS as of Q1 2026.

  • Corient Private Wealth held 110,065 shares of UBS Group worth $3.48M as of Q1 2026.
  • Corient Private Wealth sold 122,832 UBS Group shares in Q1 2026, an estimated $5.26M.
  • UBS Group made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #987 holding.
  • Corient Private Wealth first reported a position in UBS Group in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's UBS Group position peaked at $10.8M in Q4 2025.
  • 679 funds tracked by Wall St. Rank held UBS Group as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.